Latest Orca Pharmaceuticals Ltd Stories
OXFORD, England, April 28, 2014 /PRNewswire-USNewswire/ -- Orca Pharmaceuticals, a biotechnology start-up developing RORgamma inhibitors for the treatment of autoimmune diseases, has announced a further investment of $1.3 million from BioMotiv, a drug development accelerator based in Cleveland, Ohio and affiliated with The Harrington Project. Founded in 2013, the company's technology is based on intellectual property developed in the laboratory of Professor Dan Littman of New York...
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.